Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.
2.

Epigenetics of hepatocellular carcinoma: a new horizon.

Liu WR, Shi YH, Peng YF, Fan J.

Chin Med J (Engl). 2012 Jul;125(13):2349-60. Review.

PMID:
22882861
3.

Detection of epigenetic aberrations in the development of hepatocellular carcinoma.

Zhang Y.

Methods Mol Biol. 2015;1238:709-31. doi: 10.1007/978-1-4939-1804-1_37. Review.

PMID:
25421688
4.

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.

Kim HS, Shen Q, Nam SW.

J Korean Med Sci. 2015 Oct;30(10):1375-80. doi: 10.3346/jkms.2015.30.10.1375. Epub 2015 Sep 12. Review.

5.
6.

Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.

Herceg Z, Paliwal A.

Mutat Res. 2011 May-Jun;727(3):55-61. doi: 10.1016/j.mrrev.2011.04.001. Epub 2011 Apr 15. Review.

PMID:
21514401
7.

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Pogribny IP, Rusyn I.

Cancer Lett. 2014 Jan 28;342(2):223-30. doi: 10.1016/j.canlet.2012.01.038. Epub 2012 Feb 2. Review.

8.

The role and clinical implications of microRNAs in hepatocellular carcinoma.

Zhao X, Yang Z, Li G, Li D, Zhao Y, Wu Y, Robson SC, He L, Xu Y, Miao R, Zhao H.

Sci China Life Sci. 2012 Oct;55(10):906-19. doi: 10.1007/s11427-012-4384-x. Epub 2012 Oct 31. Review.

PMID:
23108868
9.

microRNA involvement in hepatocellular carcinoma.

Negrini M, Gramantieri L, Sabbioni S, Croce CM.

Anticancer Agents Med Chem. 2011 Jul;11(6):500-21. Review.

PMID:
21554203
10.

Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease.

Tian Y, Wong VW, Chan HL, Cheng AS.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):471-82. doi: 10.1016/j.semcancer.2013.08.010. Epub 2013 Sep 7. Review.

PMID:
24018165
11.

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Giordano S, Columbano A.

Hepatology. 2013 Feb;57(2):840-7. doi: 10.1002/hep.26095. Epub 2012 Dec 26. Review.

12.

Molecular and functional genetics of hepatocellular carcinoma.

Yam JW, Wong CM, Ng IO.

Front Biosci (Schol Ed). 2010 Jan 1;2:117-34. Review.

PMID:
20036934
13.

The role of microRNAs in the management of liver cancer.

Banaudha KK, Verma M.

Methods Mol Biol. 2012;863:241-51. doi: 10.1007/978-1-61779-612-8_14. Review.

PMID:
22359297
14.

A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.

Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Lam SH, Mathavan S, Parinov S, Gong Z.

Dis Model Mech. 2011 Nov;4(6):801-13. doi: 10.1242/dmm.007831. Epub 2011 Jul 4.

15.

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

Saito Y, Hibino S, Saito H.

Hepatol Res. 2014 Jan;44(1):31-42. doi: 10.1111/hepr.12147. Epub 2013 May 26.

PMID:
23617364
16.

MicroRNA and hepatocellular carcinoma: biology and prognostic significance.

Milazzo M, Fornari F, Gramantieri L.

Minerva Gastroenterol Dietol. 2011 Sep;57(3):257-71. Review.

PMID:
21769076
17.

Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.

Nishida N, Goel A.

Curr Genomics. 2011 Apr;12(2):130-7. doi: 10.2174/138920211795564359.

18.

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.

Carcinogenesis. 2010 May;31(5):766-76. doi: 10.1093/carcin/bgp250. Epub 2009 Oct 20.

PMID:
19843643
19.

The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma.

Li W, Lebrun DG, Li M.

Chin J Cancer. 2011 Aug;30(8):540-50. doi: 10.5732/cjc.011.10197. Review.

20.

Supplemental Content

Support Center